Literature DB >> 19903507

A 4-week repeated oral dose toxicity study of fucoidan from the Sporophyll of Undaria pinnatifida in Sprague-Dawley rats.

Kui-Jin Kim1, Ok-Hwan Lee, Hee-Hyun Lee, Boo-Yong Lee.   

Abstract

Fucoidan is extracted from brown seaweeds, which can have anti-coagulant, antithrombotic, antitumor, and antiviral activities. However, detailed studies on the toxicology of fucoidan have not been performed. Here we tested the toxicity of fucoidan in Sprague-Dawley rats. Fucoidan (1350mg/kg bw/day for 4 weeks) did not induce statistically significant differences in groups matched by gender with respect to body weight, ophthalmoscopy, urinalysis, hematology, and histopathology. Fucoidan did not change prothrombin time or activated partial thromboplastin time, indicating an inability to change blood clotting. This study demonstrated that fucoidan is not toxic under this administration paradigm. 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19903507     DOI: 10.1016/j.tox.2009.11.007

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  17 in total

Review 1.  Immunomodulatory dietary polysaccharides: a systematic review of the literature.

Authors:  Jane E Ramberg; Erika D Nelson; Robert A Sinnott
Journal:  Nutr J       Date:  2010-11-18       Impact factor: 3.271

2.  Fucoidan reduces the toxicities of chemotherapy for patients with unresectable advanced or recurrent colorectal cancer.

Authors:  Masahide Ikeguchi; Manabu Yamamoto; Yosuke Arai; Yoshihiko Maeta; Keigo Ashida; Kuniyuki Katano; Yasunari Miki; Takayuki Kimura
Journal:  Oncol Lett       Date:  2011-01-21       Impact factor: 2.967

Review 3.  Chemical structures and bioactivities of sulfated polysaccharides from marine algae.

Authors:  Guangling Jiao; Guangli Yu; Junzeng Zhang; H Stephen Ewart
Journal:  Mar Drugs       Date:  2011-02-08       Impact factor: 6.085

4.  Fucans, but not fucomannoglucuronans, determine the biological activities of sulfated polysaccharides from Laminaria saccharina brown seaweed.

Authors:  Diego O Croci; Albana Cumashi; Natalia A Ushakova; Marina E Preobrazhenskaya; Antonio Piccoli; Licia Totani; Nadezhda E Ustyuzhanina; Maria I Bilan; Anatolii I Usov; Alexey A Grachev; Galina E Morozevich; Albert E Berman; Craig J Sanderson; Maeve Kelly; Patrizia Di Gregorio; Cosmo Rossi; Nicola Tinari; Stefano Iacobelli; Gabriel A Rabinovich; Nikolay E Nifantiev
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

Review 5.  Therapies from fucoidan; multifunctional marine polymers.

Authors:  Janet Helen Fitton
Journal:  Mar Drugs       Date:  2011-09-30       Impact factor: 6.085

Review 6.  Marine polysaccharides from algae with potential biomedical applications.

Authors:  Maria Filomena de Jesus Raposo; Alcina Maria Bernardo de Morais; Rui Manuel Santos Costa de Morais
Journal:  Mar Drugs       Date:  2015-05-15       Impact factor: 5.118

7.  Fucoidan Extracts Ameliorate Acute Colitis.

Authors:  Qi Ying Lean; Rajaraman D Eri; J Helen Fitton; Rahul P Patel; Nuri Gueven
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

8.  Anticancer and cancer preventive properties of marine polysaccharides: some results and prospects.

Authors:  Sergey N Fedorov; Svetlana P Ermakova; Tatyana N Zvyagintseva; Valentin A Stonik
Journal:  Mar Drugs       Date:  2013-12-02       Impact factor: 5.118

Review 9.  The Therapeutic Potential of the Anticancer Activity of Fucoidan: Current Advances and Hurdles.

Authors:  Jun-O Jin; Pallavi Singh Chauhan; Ananta Prasad Arukha; Vishal Chavda; Anuj Dubey; Dhananjay Yadav
Journal:  Mar Drugs       Date:  2021-05-10       Impact factor: 5.118

10.  Toxicological Evaluation of Low Molecular Weight Fucoidan in Vitro and in Vivo.

Authors:  Pai-An Hwang; Ming-De Yan; Hong-Ting Victor Lin; Kuan-Lun Li; Yen-Chang Lin
Journal:  Mar Drugs       Date:  2016-06-24       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.